Johan Bjureberg

Johan Bjureberg

Auto-generated profile, based on publicly available information

Johan Bjureberg

Karolinska Institutet

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2015 in Journal of Psychopathology and Behavioral Assessment
Verified
Journal Article
Closed access
PDF file
JBJohan Bjureberg
Johan Bjureberg
BLBrjánn Ljótsson
Brjánn Ljótsson
MTMatthew T. Tull
Matthew T. Tull
EHErik Hedman
Erik Hedman
HSHanna Sahlin
Hanna Sahlin
KGKim L. Gratz
Kim L. Gratz

26 March 2021 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
JBJohan Bjureberg
Johan Bjureberg
MDMarie Dahlin
Marie Dahlin
ACAndreas Carlborg
Andreas Carlborg
HEHanna Edberg
Hanna Edberg
AHAxel Haglund
Axel Haglund
BRBo Runeson
Bo Runeson
Background: Suicide screening is routine practice in psychiatric emergency (PE) departments, but evidence for screening instruments is sparse. Improved identification of nascent suicide risk is important for suicide prevention. The aim of the current study was to evaluate the association between the novel Colombia Suicide Severity Rating Scale Screen Version (C-SSRS Screen) and subsequent clinical management and suicide within 1 week, 1 month and 1 year from screening.Methods: Consecutive patients (N = 18 684) attending a PE department in Stockholm, Sweden between 1 May 2016 and 31 December 2017 were assessed with the C-SSRS Screen. All patients (52.1% women; mean age = 39.7, s.d. = 16.9) were followed-up in the National Cause of Death Register. Logistic regression and receiver operating characteristic curves analyses were conducted. Optimal cut-offs and accuracy statistics were calculated.Results: Both suicidal ideation and behaviour were prevalent at screening. In total, 107 patients died by suicide during follow-up. Both C-SSRS Screen Ideation Severity and Behaviour Scales were associated with death by suicide within 1-week, 1-month and 1-year follow-up. The optimal cut-off for the ideation severity scale was associated with at least four times the odds of dying by suicide within 1 week (adjusted OR 4.7, 95% confidence interval 1.5–14.8). Both scales were also associated with short-term clinical management.Conclusions: The C-SSRS Screen may be feasible to use in the actual management setting as an initial step before the clinical assessment of suicide risk. Future research may investigate the utility of combining the C-SSRS Screen with a more thorough assessment.

11 October 2018 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
JBJohan Bjureberg
Johan Bjureberg
HSHanna Sahlin
Hanna Sahlin
EHErik Hedman-Lagerlöf
Erik Hedman-Lagerlöf
KGKim L. Gratz
Kim L. Gratz
MTMatthew T. Tull
Matthew T. Tull
BLBrjánn Ljótsson
Brjánn Ljótsson
Nonsuicidal self-injury (NSSI) is common among adolescents and associated with negative outcomes. However, treatments developed specifically for NSSI and the proposed NSSI disorder (NSSID) are scarce, and access to empirically supported treatments for NSSI in many areas is limited. Online treatments carry the potential to increase the availability of evidence-based treatments. Emotion regulation individual therapy for adolescents (ERITA) has shown promise in the treatment of adolescents with NSSID. The present study examined the feasibility, acceptability, and utility of an online version of ERITA. Twenty-five adolescents (aged 13–17) with NSSID and their parents were included in an uncontrolled open trial. Self-report and clinician-rated assessments of outcomes such as NSSI, self-destructive behaviors, emotion dysregulation, and global functioning were administered at pre-treatment, post-treatment, 3- and 6- month follow-up. Measures of NSSI, self-destructive behaviors, and emotion dysregulation were also assessed weekly during treatment. Ratings of treatment credibility, expectancy, and satisfaction were acceptable, and the therapeutic alliance and treatment completion rate (96%) were high. Adolescent participation in the treatment was associated with a statistically significant increase in past-month NSSI abstinence (p = .007), large-sized improvements in past-month NSSI frequency (55% reduction, 95% confidence interval [CI]: 29, 72; Cohen’s d = 0.88, 95% CI: 0.73, 1.06) and global functioning (d = 1.01, 95% CI: 0.77, 1.32), and medium-sized improvements in emotion dysregulation (d = 0.75, 95% CI: 0.59, 0.90) and NSSI versatility (d = 0.63, 95% CI: 0.54, 0.77) from pre- to post-treatment. These improvements were further strengthened at 3-month follow-up and maintained at 6-month follow-up. The online therapist-guided parent program was associated with small- to large-sized (ds = 0.47–1.22) improvements in adaptive parent behaviors, and these improvements were maintained or further improved upon at 6-month follow-up. Moreover, in line with the theoretical model underlying ERITA, change in emotion dysregulation mediated changes in both NSSI frequency and self-destructive behaviors over the course of treatment. Together, results suggest that online ERITA is an acceptable, feasible, and promising low-intensity treatment for adolescents with NSSID. The results of this open trial must be replicated in controlled studies. ClinicalTrials.gov ( NCT02697019 ). Registered 2 March 2016

3 July 2021 in Journal of Clinical Psychology
Verified
Journal Article
Open access
PDF file
KSKarolina Sörman
Karolina Sörman
MGMaria Å. Garke
Maria Å. Garke
NINils H. Isacsson
Nils H. Isacsson
SJSimon Jangard
Simon Jangard
JBJohan Bjureberg
Johan Bjureberg
NJNitya Jayaram-Lindström
Nitya Jayaram-Lindström
Objective: Investigating unique and shared aspects of measures of emotion regulation (ER) advances our understanding of ER as a multidimensional construct. This study aimed to investigate psychometric properties of three ER‐measures: Difficulties in Emotion Regulation Scale (DERS‐36), the abbreviated version DERS‐16, and Emotion Regulation Questionnaire (ERQ).Methods: In a community sample (N = 843; 56% females) we investigated their internal consistency, factor structure, convergence, and association with symptoms of depression, anxiety, stress and substance abuse.Results: The proposed factor structures of the DERS‐16 and the ERQ demonstrated an adequate fit. There were moderate correlations between the two DERS versions (36 and 16) and ERQ subscales Reappraisal and Suppression. Total scores of DERS‐36 and DERS‐16 demonstrated preferential associations with depression and anxiety. Corresponding associations between ERQ subscales and psychiatric symptoms were weak.Conclusion: The results indicate that DERS‐16 could be useful as an alternative, easily administered measure of ER difficulties.

1 October 2019 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Open access
MLMaria Lalouni
Maria Lalouni
BLBrjánn Ljótsson
Brjánn Ljótsson
MBMarianne Bonnert
Marianne Bonnert
RSRichard Ssegonja
Richard Ssegonja
MBMarc Benninga
Marc Benninga
OOOla Olén
Ola Olén
Scalable and effective treatments are needed for children with functional abdominal pain disorders (FAPDs). We performed a randomized controlled trial of the efficacy and cost effectiveness of cognitive behavioral therapy delivered online (Internet-CBT) compared with usual therapy. We studied children (age, 8-12 y) diagnosed with FAPDs, based on the Rome IV criteria, in Sweden from September 2016 through April 2017. The patients were assigned randomly to groups that received 10 weeks of therapist-guided, internet-delivered cognitive behavioral therapy (Internet-CBT, n = 46) or treatment as usual (treatments within the health care and school systems, including medications and visits to doctors and other health care professionals; n = 44). The primary outcome was global child-rated gastrointestinal symptom severity assessed using the Pediatric Quality of Life Gastrointestinal Symptom scale. All outcomes were collected from September 2016 through January 2018. Secondary outcomes included quality of life, gastrointestinal-specific anxiety, avoidance behaviors, and parental responses to children's symptoms. Societal costs and costs for health care consumption were collected during the treatment. Children who received Internet-CBT had a significantly larger improvement in gastrointestinal symptom severity with a medium effect size (Cohen's d = 0.46; 95% CI, 0.05-0.88; number needed to treat, 3.8) compared with children who received the treatment as usual. The children's quality of life, gastrointestinal-specific anxiety, avoidance behaviors, and parental responses to children's symptoms also improved significantly in the Internet-CBT group compared with the treatment as usual group. The effects of Internet-CBT persisted through 36 weeks of follow-up evaluation. Children who received Internet-CBT had significantly less health care use than children who received treatment as usual, with an average cost difference of US $137 (P = .011). We calculated a cost savings of US $1050 for every child treated with Internet-CBT compared with treatment as usual. In a randomized trial of pediatric patients with FAPDs, we found Internet-CBT to be clinically cost effective compared with treatment as usual. Internet-CBT has the potential to increase the availability of treatment for a number of patients and reduce health care costs. ClinicalTrials.gov: NCT02873078.

1 June 2017 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
HSHanna Sahlin
Hanna Sahlin
RKRalf Kuja-Halkola
Ralf Kuja-Halkola
JBJohan Bjureberg
Johan Bjureberg
PLPaul Lichtenstein
Paul Lichtenstein
YMYasmina Molero
Yasmina Molero
CHClara Hellner
Clara Hellner
Nonfatal deliberate self-harm (DSH) is the act of inflicting harm on oneself through the ingestion of harmful substances or causing tissue damage (eg, cutting or burning oneself).1 Although most epidemiologic research in this area has focused on DSH as a risk factor for completed suicide,2-5 the term also includes self-harming acts performed without suicidal intent (eg, behaviors aimed at regulating an intense negative state).6-8 Typically, DSH debuts between the ages of 12 and 14 years, and it is increasingly being recognized as a serious global health problem9-11 and as a risk factor for future attempted or completed suicide5 and for the development of psychiatric disorders, substance abuse, and antisocial behavior.12-14